Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1964;30(3):327–341.

Progress in chemotherapy of cancer

W Davis, L F Larionov
PMCID: PMC2554827  PMID: 14163957

Abstract

The chemotherapy of cancer, in relation to surgery and radiotherapy, is a new method of attack. Its development, which started virtually in the 1940's, was reviewed by the WHO Expert Committee on Chemotherapy of Cancer that met in September 1961. The report of the Committee dealt with experimental and clinical studies in this field critically, but also to a necessary degree, comprehensively. The design and mechanism of action of the drugs, their biological screening and subsequent clinical trials were discussed, and a review was presented of the clinically available drugs and the neoplasms for which they were indicated. In the two years that have elapsed since the report was drawn up many new compounds have been tested and some have had clinical trials. There have been developments, too, in methods of administration. All these new developments are discussed in the present paper.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANSFIELD F. J., SCHROEDER J. M., CURRERI A. R. Five years clinical experience with 5-fluorouracil. JAMA. 1962 Jul 28;181:295–299. doi: 10.1001/jama.1962.03050300015003. [DOI] [PubMed] [Google Scholar]
  2. AUSTIN C., BERGSAGEL D. E., SPRAGUE C. C. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. VI. Metasarcolysin. Cancer Chemother Rep. 1962 Aug;21:107–112. [PubMed] [Google Scholar]
  3. BARONE J. A. TRIFLUOROMETHYL COMPOUNDS RELATED TO NUCLEIC ACID BASES. J Med Chem. 1963 Jan;6:39–42. doi: 10.1021/jm00337a009. [DOI] [PubMed] [Google Scholar]
  4. BEAMAN A. G., ROBINS R. K. THE SYNTHESIS OF 6-FLUORO-9-METHYLPURINE. J Med Pharm Chem. 1962 Nov;91:1067–1074. doi: 10.1021/jm01241a001. [DOI] [PubMed] [Google Scholar]
  5. BOTTINI A. T., DEV V. STRUCTURE-ACTIVITY RELATIONSHIPS OF ETHYLENIMINES. II. METHYL- SUBSTITUTED DERIVATIVES OF TETRAMIN. J Med Pharm Chem. 1962 Sep;91:925–932. doi: 10.1021/jm01240a005. [DOI] [PubMed] [Google Scholar]
  6. DE CARVALHO S. [Preliminary experimentation with specific immunotherapy of neoplastic disease in man. I. Immediate effects of hyperimmune equine gamma globulins]. Cancer. 1963 Mar;16:306–330. doi: 10.1002/1097-0142(196303)16:3<306::aid-cncr2820160305>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. DYER E., REITZ J. M., FARRIS R. E., Jr CARBAMATES DERIVED FROM AMINOPURINES. J Med Chem. 1963 May;6:289–291. doi: 10.1021/jm00339a015. [DOI] [PubMed] [Google Scholar]
  8. ESPINER H. J., VOWLES K. D., WALKER R. M. Cancer chemotherapy by intra-arterial infusion. A preliminary report concerning tumours of the head and neck. Lancet. 1962 Jan 27;1(7222):177–181. doi: 10.1016/s0140-6736(62)91074-7. [DOI] [PubMed] [Google Scholar]
  9. FAULKNER R. D., LAMBOOY J. P. SYNTHESIS AND BIOLOGICAL ACTIVITY OF 7,8-DISUBSTITUTED ISOALLOXAZINES. SYNTHESIS OF NITROGEN MUSTARD DERIVATIVES. J Med Chem. 1963 May;6:292–294. doi: 10.1021/jm00339a016. [DOI] [PubMed] [Google Scholar]
  10. FRIEDMAN O. M., BOGER E., GRUBLIAUSKAS V., SOMMER H. SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY. J Med Chem. 1963 Jan;6:50–58. doi: 10.1021/jm00337a012. [DOI] [PubMed] [Google Scholar]
  11. FU S. C. PARA-(N-BIS-(2-CHLOROETHYL))-AMINOBENZOYLGLUTAMIC ACID. J Med Pharm Chem. 1962 Jan;5:33–41. doi: 10.1021/jm01236a004. [DOI] [PubMed] [Google Scholar]
  12. GOLOMB F. M., POSTEL A. H., HALL A. B., GUMPORT S. L., COX K. R., WRIGHT J. C. Chemotherapy of human cancer by regional perfusion. Report of 52 perfusions. Cancer. 1962 Jul-Aug;15:828–845. doi: 10.1002/1097-0142(196207/08)15:4<828::aid-cncr2820150420>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  13. GRECO C. V., NYBERG W. H., CHENG C. C. SYNTHESIS OF SYDNONES AND SYDNONE IMINES. J Med Pharm Chem. 1962 Jul;91:861–865. doi: 10.1021/jm01239a022. [DOI] [PubMed] [Google Scholar]
  14. HANDSCHUMACHER R. E., CREASEY W. A., FINK M. E., CALABRESI P., WELCH A. D. Pharmacological and clinical studies with triacetyl 6-azauridine. Cancer Chemother Rep. 1962 Feb;16:267–269. [PubMed] [Google Scholar]
  15. HYDE K. A., ACTON E., SKINNER W. A., GOODMAN L., GREENBERG J., BAKER B. R. POTENTIAL ANTICANCER AGENTS. LXII. THE RELATIONSHIP OF CHEMICAL STRUCTURE TO ANTILEUKEMIC ACTIVITY WITH ANALOGS OF 1-METHYL-3-NITRO-1-NITROSOGUANIDINE (NSC-9369). II. J Med Pharm Chem. 1962 Jan;5:1–14. doi: 10.1021/jm01236a001. [DOI] [PubMed] [Google Scholar]
  16. ITAI T., ITO G. Potential anti-cancer agents. VII. Azidopurine derivatives. Chem Pharm Bull (Tokyo) 1962 Dec;10:1141–1145. doi: 10.1248/cpb.10.1141. [DOI] [PubMed] [Google Scholar]
  17. IWAMOTO R. H., ACTON E. M., ROSS L. O., SKINNER W. A., BAKER B. R., GOODMAN L. POTENTIAL ANTICANCER AGENTS. LXXIX. AROMATIC NITROGEN MUSTARDS DERIVED FROM CYSTEINE. J Med Chem. 1963 Jan;6:43–46. doi: 10.1021/jm00337a010. [DOI] [PubMed] [Google Scholar]
  18. KELLEY G. G., WHEELER G. P., MONTGOMERY J. A. The effects of a series of 9-alkylpurines on the growth of sensitive and 6-MP-resistant H. Ep. 2 cells. Cancer Res. 1962 Apr;22:329–333. [PubMed] [Google Scholar]
  19. KOPPEL H. C., SPRINGER R. H., ROBINS R. K., CHENG C. C. PYRIMIDINES. VIII. PYRIMIDINE DERIVATIVES OF THIOGUANINE. J Med Pharm Chem. 1962 May;91:639–641. doi: 10.1021/jm01238a024. [DOI] [PubMed] [Google Scholar]
  20. KOSHIURA R. H., KAGOTANI Y., UJIIE T. Experimental anticancer studies. XVI. Preparation and anticancer activity of 4-amino-6-hexylresorcinol on Ehrlich carcinoma in mice. Chem Pharm Bull (Tokyo) 1962 Jun;10:528–532. doi: 10.1248/cpb.10.528. [DOI] [PubMed] [Google Scholar]
  21. KUEHNE M. E., KONOPKA E. A. DIHYDRO-1,3-OXAZINES AS ANTITUMOR AGENTS. J Med Pharm Chem. 1962 Mar;5:257–280. doi: 10.1021/jm01237a005. [DOI] [PubMed] [Google Scholar]
  22. KUEHNE M. E., KONOPKA E. A., LAMBERT B. F. STEROIDAL DIHYDRO-1,3-OXAZINES AS ANTITUMOR AGENTS. J Med Pharm Chem. 1962 Mar;5:281–296. doi: 10.1021/jm01237a006. [DOI] [PubMed] [Google Scholar]
  23. KUPCHAN S. M., DOSKOTCH R. W. TUMOR INHIBITORS. I. ARISTOLOCHIC ACID, THE ACTIVE PRINCIPLE OF ARISTOLOCHIA INDICA. J Med Pharm Chem. 1962 May;91:657–659. doi: 10.1021/jm01238a029. [DOI] [PubMed] [Google Scholar]
  24. LEWIS L. R., NOELL C. W., BEAMAN A. G., ROBINS R. K. THE PREPARATION AND ANTITUMOR ACTIVITY OF CERTAIN DERIVATIVES OF 6-MERCAPTOPURINE. J Med Pharm Chem. 1962 May;91:607–617. doi: 10.1021/jm01238a018. [DOI] [PubMed] [Google Scholar]
  25. LOMBARDINO J. G. 4,6-DIAMINO-1-ALKYL-1,2-DIHYDRO-S-TRIAZINES. J Med Chem. 1963 Mar;6:213–214. doi: 10.1021/jm00338a035. [DOI] [PubMed] [Google Scholar]
  26. MAUTNER H. G., CHU S. H., JAFFE J. J., SARTORELLI A. C. THE SYNTHESIS AND ANTINEOPLASTIC PROPERTIES OF SELENOGUANINE, SELENOCYTOSINE AND RELATED COMPOUNDS. J Med Chem. 1963 Jan;6:36–39. doi: 10.1021/jm00337a008. [DOI] [PubMed] [Google Scholar]
  27. MONTGOMERY J. A., HEWSON K., TEMPLE C., Jr SYNTHESIS OF POTENTIAL ANTICANCER AGENTS. XXX. (1-AZIRIDINYL)PURINES. J Med Pharm Chem. 1962 Jan;5:15–24. doi: 10.1021/jm01236a002. [DOI] [PubMed] [Google Scholar]
  28. NOELL C. W., ROBINS R. K. THE ANTITUMOR ACTIVITY OF 2-AMINO-6-ALKYLTHIO-9-(BETA-DRIBOFURANOSYLPURINES AND RELATED DERIVATIVES OF 2-AMINO-6-PURINETHIOL (THIOGUANINE). J Med Pharm Chem. 1962 Nov;91:1074–1085. doi: 10.1021/jm01241a002. [DOI] [PubMed] [Google Scholar]
  29. NOELL C. W., SMITH D. W., ROBINS R. K. SYNTHESIS AND ANTITUMOR ACTIVITY OF 2-AMINO-1-METHYLPURINE- 6-THIONE. J Med Pharm Chem. 1962 Sep;91:996–999. doi: 10.1021/jm01240a012. [DOI] [PubMed] [Google Scholar]
  30. PAPANASTASSIOU Z. B., BARDOS T. J. SYNTHESIS OF POTENTIAL "DUAL ANTAGONISTS." I. SOME BIS(1-AZIRIDINYL)PHOSPHINYL CARBAMATES AND THEIR STRUCTURAL ANALOGS. J Med Pharm Chem. 1962 Sep;91:1000–1007. [PubMed] [Google Scholar]
  31. PETTIT G. R., BAUMANN M. F., RANGAMMAL K. N. ANTINEOPLASTIC AGENTS. V. THE AROMATIC SYSTEM OF PODOPHYLLOTOXIN (PART B). J Med Pharm Chem. 1962 Jul;91:800–808. doi: 10.1021/jm01239a014. [DOI] [PubMed] [Google Scholar]
  32. PETTIT G. R., SETTEPANI J. A. ANTINEOPLASTIC AGENTS. IV. MANNICH BASE NITROGEN MUSTARDS (PART A). J Med Pharm Chem. 1962 Mar;5:296–302. doi: 10.1021/jm01237a007. [DOI] [PubMed] [Google Scholar]
  33. PODREBARAC E. G., NYBERG W. H., FRENCH F. A., CHENG C. C. STUDIES ON METHYLGLYOXAL BIS(GUANYLHYDRAZONE) ANALOGS. I. HOMOLOGS OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE). J Med Chem. 1963 May;6:283–288. doi: 10.1021/jm00339a014. [DOI] [PubMed] [Google Scholar]
  34. REGELSON W., HOLLAND J. R. Clinical experience with methylglyoxal bis (guanylhydrazone) dihydrochloride: a new agent with clinical activity in acute myelocytic leukemia and the lymphomas. Cancer Chemother Rep. 1963 Mar;27:15–26. [PubMed] [Google Scholar]
  35. RIEBELING M. Massive intra-aortic injections of nitrogen mustard (Dichloren), 5-fluorouracil, nitromin, and endoxan prior to roentgen irradiation for advanced tumors of the uterus. Radiology. 1962 Jul;79:132–133. doi: 10.1148/79.1.132. [DOI] [PubMed] [Google Scholar]
  36. SAKURAI Y., AOSHIMA M. Studies on carcinostatic substances. XLI. Preparation of azide derivatives of 1,1-bis(2-chloroethyl)hydrazine. Chem Pharm Bull (Tokyo) 1962 Oct;10:979–981. doi: 10.1248/cpb.10.979. [DOI] [PubMed] [Google Scholar]
  37. SHANKMAN S., HIGA S., LEW F., ROBERTS M. E. SYNTHESIS OF PEPTIDES OF 1-AMINOCYCLOPENTANECARBOXYLIC ACID. J Med Pharm Chem. 1962 Jan;5:42–49. doi: 10.1021/jm01236a005. [DOI] [PubMed] [Google Scholar]
  38. SOUTHAM C. M. Applications of immunology to clinical cancer. Past attempts and future possibilities. Cancer Res. 1961 Oct;21:1302–1316. [PubMed] [Google Scholar]
  39. STEARNS B., LOSEE K. A., BERNSTEIN J. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT. J Med Chem. 1963 Mar;6:201–201. doi: 10.1021/jm00338a026. [DOI] [PubMed] [Google Scholar]
  40. STOVNER J., ENGSETH A., BRENNHOVD I. Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase. Cancer Chemother Rep. 1962 Aug;21:147–148. [PubMed] [Google Scholar]
  41. SVOBODA G. H., JOHNSON I. S., GORMAN M., NEUSS N. Current status of research on the alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don). J Pharm Sci. 1962 Aug;51:707–720. doi: 10.1002/jps.2600510802. [DOI] [PubMed] [Google Scholar]
  42. TSOU K. C., HOEGERLE K. SYNTHESIS OF HEXAHYDROAZEPINYL-BIS(AZIRIDINYL)PHOSPHINE OXIDE, SULFIDE, AND RELATED COMPOUNDS FOR CANCER THERAPY. J Med Chem. 1963 Jan;6:47–49. doi: 10.1021/jm00337a011. [DOI] [PubMed] [Google Scholar]
  43. VOGEL A. W., SLOBODA A. E., TOMCUFCIK A. S., CHILD R. G. Effect of a new anticancer agent, 1,4-dimethyl-1,4-diphenyl-2-tetrazene. on a transplantable mammarv adenocarcinoma (72j) and spontaneous mouse breast tumours. Nature. 1963 Jan 5;197:85–86. doi: 10.1038/197085b0. [DOI] [PubMed] [Google Scholar]
  44. WILEY R. H., CLEVENGER R. L. ALDEHYDE HYDRAZONE DERIVATIVES IN CANCER CHEMOTHERAPY. J Med Pharm Chem. 1962 Nov;91:1367–1371. doi: 10.1021/jm01241a031. [DOI] [PubMed] [Google Scholar]
  45. WITTEN B. Enzyme-alterable alkylating agents. I. Synthesis, chemical properties, and toxicities of sulfur mustards containing enzyme-susceptible amide bonds. Cancer. 1962 Sep-Oct;15:1041–1055. doi: 10.1002/1097-0142(196209/10)15:5<1041::aid-cncr2820150521>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  46. WOLBERG W. H., BROWN R. R. Autoradiographic studies of in vitro incorporation of uridine and thymidine by human tumor tissue. Cancer Res. 1962 Oct;22:1113–1119. [PubMed] [Google Scholar]
  47. WRIGHT J. C., COBB J. P., GUMPORT S. L., SAFADI D., WALKER D. G., GOLOMB F. M. Further investigation of the relation between the clinical and tissue culture response to chemotherapeutic agents on human cancer. Cancer. 1962 Mar-Apr;15:284–293. doi: 10.1002/1097-0142(196203/04)15:2<284::aid-cncr2820150212>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  48. ZELLER P., GUTMANN H., HEGEDUS B., KAISER A., LANGEMANN A., MULLER M. Methylhydrazine derivatives, a new class of cytotoxic agents. Experientia. 1963 Mar 15;19:129–129. doi: 10.1007/BF02171588. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES